Millennium Management

Millennium Management

Signal active

Investment Firm

Overview

Millennium Management is an investment management company. They seek an array of investment strategies across industry sectors, asset classes, and geographies. Their entrepreneurial environment enables them to manage their investment processes. They also seek to accelerate by providing sophisticated resources and technology.

Highlights

Founded

1989

Industry

Financial Services

Employees

5001-10000

Investment

15

Lead Investment

1

Exits

7

Stages

Early Stage Venture, Late Stage Venture, Private Equity

Investor Type

Hedge Fund

Location

New York, New York, United States, North America

Contact Information

Social

Profile Resume

Millennium Management, established in 1989 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Medical, Financial Services, Finance, Photography, Asset Management, Wealth Management, Retirement. The organization boasts a portfolio of 14 investments, with an average round size of $257.2M and 7 successful exits. Their recent investments include Cardurion Pharmaceuticals, Farallon Capital Management, Fidelity, New Enterprise Associates, Google Ventures. The highest investment round they participated in was $547.7B. Among their most notable exits are Cardurion Pharmaceuticals and Farallon Capital Management. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Julien Sallmard

Julien Sallmard

Senior Portfolio Manager

imagePlace Phil Medici

Phil Medici

Equity Trader

imagePlace Ross Garon

Ross Garon

Head of Quantitative Strategies

imagePlace Daniel Elbaz

Daniel Elbaz

Senior Quantitative Researcher

imagePlace Dennis Chao

Dennis Chao

Analyst

imagePlace Michael Brams

Michael Brams

Head of Compute Engineering and Cloud

Investment portfolio

Millennium Management has made 15 investments. Their most recent investment was on Jul 16, 2024, when Cardurion Pharmaceuticals raised $260.0M.

Millennium Management has made 2 diversity investments. Their most recent diversity investment was on Jan 25, 2022, when Metagenomi raised $175.0M.

investments

15

Diversity investments

2

Lead investments

1

Number of exits

7

Investments

15

Annouced DateOrganization NameIndustryMoney Raised
Jan 25, 2022
Metagenomi Metagenomi
Biotechnology175.0M
Nov 17, 2022
One97 Communications One97 Communications
Information Technology200.0M
May 25, 2023
Carmot Therapeutics Carmot Therapeutics
Biotechnology150.0M
Jul 16, 2024
Cardurion Pharmaceuticals Cardurion Pharmaceuticals
Biotechnology260.0M

Exits

7

Funding Timeline

Funding rounds

15

Investors

0

Funds

0

Funding Rounds

15

Millennium Management has raised 15 rounds. Their latest funding was raised on Jul 16, 2024 from a Series B - Cardurion Pharmaceuticals round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jan 25, 2022
Series B - Metagenomi Series B - Metagenomi
-175.0M-
Nov 17, 2022
Post-IPO Secondary - One97 Communications Post-IPO Secondary - One97 Communications
-200.0M-
May 25, 2023
Series E - Carmot Therapeutics Series E - Carmot Therapeutics
-150.0M-
Jul 16, 2024
Series B - Cardurion Pharmaceuticals Series B - Cardurion Pharmaceuticals
-260.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.